SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies

WATERTOWN, Mass. and RESEARCH TRIANGLE PARK, N.C., Nov. 7, 2019 /PRNewswire/ -- SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to create tolerizing antigen carriers......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Thursday, 7 November

Share |